aDepartment of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Hidaka, Saitama

bDivision of Respiratory Medicine, Gunma Prefectural Cancer Center

cDivision of Pharmacy, Gunma Prefectural Cancer Center, Ota

dDivision of Pharmacy, Fujioka General Hospital, Fujioka

eDivision of Pharmacy, Kiryu Kosei General Hospital, Kiryu

fDivision of Pharmacy, Haramachi Red Cross Hospital, Agatsuma-gun

gDepartment of Pharmacy, Tatebayashi Kosei General Hospital, Tatebayashi

hDivision of Pharmacy, Ota Memorial Hospital, Ota

iDivision of Pharmacy, Tone Central Hospital, Numata

jDivision of Pharmacy, Gunma Saiseikai Maebashi Hospital, Maebashi

kDivision of Pharmacy, Japan Community Health Care Organization (JCHO) Gunma Chuo Hospital, Maebashi

lGraduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare

mDivision of Pharmacy, Hidaka Hospital. 886 Nakao, Takasaki

nDivision of Palliative Care, Gunma Prefectural Cancer Center, Ota, Gunma, Japan

Received 7 December 2023 Accepted 21 January 2024.

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website, www.eurojgh.com.

Correspondence to Hisao Imai, MD, PhD, Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama 350-1298, Japan, Tel: +81 42 984 4111; fax: +81 42 984-4741; e-mail: [email protected]